Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
0.224
+0.004 (2.00%)
At close: Nov 20, 2024, 4:00 PM
0.220
-0.004 (-1.79%)
Pre-market: Nov 21, 2024, 7:38 AM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $5.38 million as of November 21, 2024. Its market cap has decreased by -89.71% in one year.
Market Cap
5.38M
Enterprise Value
13.02M
1-Year Change
-89.71%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $5.38M, a decrease of -90.81%. That is a compound annual growth rate of -54.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 5.73M | -75.73% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CNS Pharmaceuticals | 5.95M |
| Viracta Therapeutics | 5.91M |
| NewGenIvf Group | 5.89M |
| Organovo Holdings | 5.84M |
| Cutera | 5.79M |
| TransCode Therapeutics | 5.70M |
| Biomerica | 5.64M |
| SunLink Health Systems | 5.56M |